Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Amygdala abnormalities in first-degree relatives of individuals with schizophrenia unmasked by benzodiazepine challenge.

Wolf DH, Satterthwaite TD, Loughead J, Pinkham A, Overton E, Elliott MA, Dent GW, Smith MA, Gur RC, Gur RE.

Psychopharmacology (Berl). 2011 Dec;218(3):503-12. doi: 10.1007/s00213-011-2348-7. Epub 2011 May 21.

2.

Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing.

Paulus MP, Feinstein JS, Castillo G, Simmons AN, Stein MB.

Arch Gen Psychiatry. 2005 Mar;62(3):282-8.

PMID:
15753241
3.

Benzodiazepines counteract rostral anterior cingulate cortex activation induced by cholecystokinin-tetrapeptide in humans.

Leicht G, Mulert C, Eser D, Sämann PG, Ertl M, Laenger A, Karch S, Pogarell O, Meindl T, Czisch M, Rupprecht R.

Biol Psychiatry. 2013 Feb 15;73(4):337-44. doi: 10.1016/j.biopsych.2012.09.004. Epub 2012 Oct 8.

PMID:
23059050
4.

DHEA enhances emotion regulation neurocircuits and modulates memory for emotional stimuli.

Sripada RK, Marx CE, King AP, Rajaram N, Garfinkel SN, Abelson JL, Liberzon I.

Neuropsychopharmacology. 2013 Aug;38(9):1798-807. doi: 10.1038/npp.2013.79. Epub 2013 Apr 3.

5.

Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose-response study.

Riba J, Rodríguez-Fornells A, Urbano G, Morte A, Antonijoan R, Barbanoj MJ.

Psychopharmacology (Berl). 2001 Oct;157(4):358-67.

PMID:
11605094
6.

Temporal profile of brain response to alprazolam in patients with generalized anxiety disorder.

Brown GG, Ostrowitzki S, Stein MB, von Kienlin M, Liu TT, Simmons A, Wierenga C, Stein OY, Bruns A, Bischoff-Grethe A, Paulus M.

Psychiatry Res. 2015 Sep 30;233(3):394-401. doi: 10.1016/j.pscychresns.2015.06.016. Epub 2015 Jun 30.

PMID:
26211623
7.

The impact of 5-HTTLPR on acute serotonin transporter blockade by escitalopram on emotion processing: preliminary findings from a randomised, crossover fMRI study.

Outhred T, Das P, Dobson-Stone C, Felmingham KL, Bryant RA, Nathan PJ, Malhi GS, Kemp AH.

Aust N Z J Psychiatry. 2014 Dec;48(12):1115-25. doi: 10.1177/0004867414533837. Epub 2014 May 8.

PMID:
24810870
8.

Facilitation of emotion regulation with a single dose of escitalopram: A randomized fMRI study.

Outhred T, Das P, Felmingham KL, Bryant RA, Nathan PJ, Malhi GS, Kemp AH.

Psychiatry Res. 2015 Sep 30;233(3):451-7. doi: 10.1016/j.pscychresns.2015.07.018. Epub 2015 Jul 13.

PMID:
26210693
9.

Effect of levodopa on healthy volunteers' facial emotion perception: an FMRI study.

Delaveau P, Salgado-Pineda P, Wicker B, Micallef-Roll J, Blin O.

Clin Neuropharmacol. 2005 Nov-Dec;28(6):255-61.

PMID:
16340378
10.

Neuroendocrine and sympathetic responses to an orexin receptor antagonist, SB-649868, and alprazolam following insulin-induced hypoglycemia in humans.

Patel AX, Miller SR, Nathan PJ, Kanakaraj P, Napolitano A, Lawrence P, Koch A, Bullmore ET.

Psychopharmacology (Berl). 2014 Oct;231(19):3817-28. doi: 10.1007/s00213-014-3520-7. Epub 2014 Apr 26.

11.

Increased amygdala activation during automatic processing of facial emotion in schizophrenia.

Rauch AV, Reker M, Ohrmann P, Pedersen A, Bauer J, Dannlowski U, Harding L, Koelkebeck K, Konrad C, Kugel H, Arolt V, Heindel W, Suslow T.

Psychiatry Res. 2010 Jun 30;182(3):200-6. doi: 10.1016/j.pscychresns.2010.03.005. Epub 2010 May 20.

PMID:
20488680
12.

Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects.

Mumford GK, Rush CR, Griffiths RR.

J Pharmacol Exp Ther. 1995 Feb;272(2):570-80.

PMID:
7853170
13.

Increased sensitivity to alprazolam in females with a paternal history of alcoholism.

Evans SM, Levin FR, Fischman MW.

Psychopharmacology (Berl). 2000 Jun;150(2):150-62.

PMID:
10907668
14.

Impaired facial emotion recognition and reduced amygdalar volume in schizophrenia.

Namiki C, Hirao K, Yamada M, Hanakawa T, Fukuyama H, Hayashi T, Murai T.

Psychiatry Res. 2007 Oct 15;156(1):23-32. Epub 2007 Aug 28.

PMID:
17728113
15.

Functional magnetic resonance imaging of alprazolam-induced changes in humans with familial alcoholism.

Streeter CC, Ciraulo DA, Harris GJ, Kaufman MJ, Lewis RF, Knapp CM, Ciraulo AM, Maas LC, Ungeheuer M, Szulewski S, Renshaw PF.

Psychiatry Res. 1998 May 20;82(2):69-82.

PMID:
9754450
16.

The (lack of) effect of alprazolam on eating behavior in anorexia nervosa: a preliminary report.

Steinglass JE, Kaplan SC, Liu Y, Wang Y, Walsh BT.

Int J Eat Disord. 2014 Dec;47(8):901-4. doi: 10.1002/eat.22343. Epub 2014 Aug 19.

PMID:
25139178
17.

Differences in pharmacodynamics but not pharmacokinetics between subjects with panic disorder and healthy subjects after treatment with a single dose of alprazolam.

Kaplan GB, Greenblatt DJ, Ehrenberg BL, Goddard JE, Harmatz JS, Shader RI.

J Clin Psychopharmacol. 2000 Jun;20(3):338-46.

PMID:
10831021
18.

Validating a human model for anxiety using startle potentiated by cue and context: the effects of alprazolam, pregabalin, and diphenhydramine.

Baas JM, Mol N, Kenemans JL, Prinssen EP, Niklson I, Xia-Chen C, Broeyer F, van Gerven J.

Psychopharmacology (Berl). 2009 Jul;205(1):73-84. doi: 10.1007/s00213-009-1516-5. Epub 2009 May 5. Erratum in: Psychopharmacology (Berl). 2010 Jun;210(3):451.

19.

Oxytocin promotes facial emotion recognition and amygdala reactivity in adults with asperger syndrome.

Domes G, Kumbier E, Heinrichs M, Herpertz SC.

Neuropsychopharmacology. 2014 Feb;39(3):698-706. doi: 10.1038/npp.2013.254. Epub 2013 Sep 26.

20.

Amygdala activation modulated by levodopa during emotional recognition processing in healthy volunteers: a double-blind, placebo-controlled study.

Delaveau P, Salgado-Pineda P, Micallef-Roll J, Blin O.

J Clin Psychopharmacol. 2007 Dec;27(6):692-7.

PMID:
18004139

Supplemental Content

Support Center